---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-024879"
form_type: "8-K"
ticker: "ASMB"
cik: "0001426800"
company_name: "ASSEMBLY BIOSCIENCES, INC."
filed_at: "2023-05-30T23:59:59+00:00"
generated_at: "2026-06-14T11:30:36.116759+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Stockholders reject authorized share increase to 225M at ASMB annual meeting

## Summary
- All eight director nominees elected with no opposition.
- Say-on-pay advisory approved (10.6M for, 1.7M against).
- Ratification of Ernst & Young as auditor for FY2023 approved (21.5M for).
- Amendment to 2018 Stock Incentive Plan increasing share reserve from 8.6M to 10.6M shares approved.
- Proposal to increase authorized common stock from 150M to 225M shares failed, limiting future equity issuance.

## SEC filing metadata
- accession: 0000950170-23-024879
- form_type: 8-K
- ticker: ASMB
- cik: 0001426800
- company_name: ASSEMBLY BIOSCIENCES, INC.
- filed_at: 2023-05-30T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1426800/000095017023024879/0000950170-23-024879-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1426800/000095017023024879/asmb-20230525.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-024879
- JSON: https://secwatch.observer/filing/0000950170-23-024879.json
- Plain text: https://secwatch.observer/filing/0000950170-23-024879.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.